FHAM
EW icon

Folger Hill Asset Management’s Edwards Lifesciences EW Stock Holding History

Folger Hill Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,021
Closed -$474K – 215
2017
Q2 		$474K Buy
+12,021
New +$439K 0.04% 213

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Folger Hill Asset Management's EW Position: Q3 2017 in Review

Folger Hill Asset Management sold out of Edwards Lifesciences (EW) in Q3 2017, closing a stake of 12,021 shares — an estimated $474K sold.

Folger Hill Asset Management first reported a position in EW in Q2 2017 and held it in 1 quarter. The position peaked at $474K in Q2 2017. 740 funds tracked by Wall St. Rank hold EW as of Q3 2017.

  • Folger Hill Asset Management reported no remaining Edwards Lifesciences position as of Q3 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 12,021 Edwards Lifesciences shares in Q3 2017, an estimated $474K.
  • Folger Hill Asset Management first reported a position in Edwards Lifesciences in Q2 2017 and held it in 1 quarter.
  • Folger Hill Asset Management's Edwards Lifesciences position peaked at $474K in Q2 2017.
  • 740 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Folger Hill Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.